Plasmodium falciparum: Mechanisms of innate and acquired protection against Plasmodium falciparum in Javanese transmigrant adults and children newly resident in malaria-endemic Northwest Papua

Advances in Experimental Medicine and Biology

Volumn 531, Issue , 2003, Pages 83-102

  Keenihan, Sarah Hudson ^a   Gramzinksi, Robert ^a   Ratiwayanto, Sutanti ^a   Hadiputranto, Hilda ^a   Riberu, Wiwi ^a   Soebianto, Saraswati ^a   Rusjdy, Faisal ^a   Syafruddin, Din ^b   Kartikasari, Apriliina ^b   Djojosubroto, Meta ^b   Setianingsih, Iswari ^b   Harahap, Alida ^b   Krisin, ^a   Fryauff, David ^c   Richie, Thomas ^c   Charoenvit, Yupin ^c   Marwoto, Hariyani A ^d   Kumar, Sanjai ^c   Hoffman, Stephen ^c   Marzuki, Sangkot ^b   Baird, Kevin ^a   more..

^a US Navy Medical Research Unit 2   (Indonesia)

^b EIJKMAN INSTITUTE FOR MOLECULAR BIOLOGY   (Indonesia)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

^d LITBANGKES   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; ANTIMALARIAL AGENT; BETA GLOBIN; CHLOROQUINE; DUFFY RECEPTOR; ERYTHROCYTE ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGE; ALPHA THALASSEMIA; ANTIBODY TITER; BETA THALASSEMIA; BLOOD SAMPLING; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; ELLIPTOCYTOSIS; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; GENETIC POLYMORPHISM; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; INDONESIA; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALARIA CONTROL; MALARIA FALCIPARUM; MEROZOITE; MIGRATION; NONHUMAN; PAPUA NEW GUINEA; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REINFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZONT; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM;

EID: 0041883802     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0059-9_7     Document Type: Conference Paper

References (51)

1. Aribot, G., Rogier, C., Sarthou, J.L., Trape, J.F., Balde, A.T., Druilhe, P., and Roussilhon, C., 1996, Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, West Africa). Am. J. Trop. Med. Hyg. 54: 449-457.
2. Baird, J.K., 1995, Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol. Today 11: 105-111.
3. Baird, J.K., 1998, Age-dependent characteristics of protection versus susceptibility to Plasmodium falciparum. Ann. Trop. Med. Parasitol. 92: 367-390.
4. Baird, J.K., Jones, T.R., Danudirgo, E.W., Annis, B.A., Bangs, M.J., Basri, H., Purnomo, and Masbar, S., 1991 Age-dependent acquired protection against Plasmodium falciparum in people having two years exposure to hyperendemic malaria. Am. J. Trop. Med. Hyg. 45: 65-76.
5. Baird, J.K., Jones, T.R., Marwoto, H., Bangs, M.J., Surwarno, S.S.H., Leksana, B., and Masbar, S., 1990 Seroepidemiologic assessment of malaria using a ELISA for ring-infected erythrocyte surface antigen of Plasmodium falciparum. Bul. Penelitian Kesehatan 18: 1-9.
6. Baird, J.K., Purnomo, Basri, H., Bangs, M.J., Andersen, E.M., Jones, T.R., Masbar, S., Harjosuwarno, S., Subianto, B., and Arbani, P.R., 1993, Age-specific prevalence of Plasmodium falciparum among six populations with limited histories of exposure to endemic malaria. Am. J. Trop. Med. Hyg. 49: 707-719.
7. Banchereau, J., and Steinman, R.M., 1998, Dendritic cells and the control of immunity. Nature 392: 245-252.
8. Blackman, M.J., Heidrich, H.G., Donachie, S., McBride, J.S., and Holder, A.A., 1990, A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172: 379-382.
9. Bouharoun-Tayoun, H., Attanath, P., Sabchareon, A., Chongsuphajaisiddhi, T., and Druilhe, P., 1990, Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172: 1633-1641.
10. Bouharoun-Tayoun, H., and Druilhe, P., 1992, Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect. Immun. 60: 1473-1481.
11. Bruce, L.J., and Tanner M.J., 1999, Erythroid band 3 variants and disease. Baillieres Best Pract. Res. Clin. Haematol. 12: 637-654.
12. Cavanagh, D. R., Elhassan, I.M., Roper, C., Robinson, V.J., Giha, H., Holder, A.A., Hviid, L., Theander, T.G., Arnot, D.E., and McBride, J.S., 1998, A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J. Immunol. 161(1): 347-359.
13. Cavanagh, D.R., Dobano, C., Elhassan, I.M., Marsh, K., Elhassan, A., Hviid, L., Khalil, E.A., Theander, T.G., Arnot, D.E., and McBride, J.S, 2001, Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum. Infect. Immun. 69(2): 1207-1211
14. Christopher, S.R., 1924, The mechanism of immunity against malaria in communities living under hyperendemic conditions. Indian J. Med. Res. 12: 273-294.
15. Clegg, J.B., and Weatherall, D.J., 1999, Thalassemia and malaria: new insights into an old problem. Proc. Assoc. Am. Physicians 111: 278-282.
16. Cohen, S., and McGregor, I.A., and Carrington, S., 1961, Gamma globulin and acquired immunity to malaria. Nature 192: 773-777.
17. Cooke, G.S., and Hill, A.V., 2001, Genetics of susceptibility to human infectious disease. Nat. Rev. Genet. 2: 967-977.
18. Day, K.P., and Marsh, K., 1991, Naturally acquired immunity to Plasmodium falciparum. Immunol. Today 12: A68-71.
19. Diggs, C.L., Wellde B.T., Anderson J.S., Weber R.M., and Rodriguez J.E., 1972, The protective effect of african human immunoglobulin G in Aotus trivirgatus infected with asian Plasmodium falciparum. Proc. Helminthol. Soc. Wash. 39: 449-457.
20. Doolan, D.L., and Hoffman, S., 2001, DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation. Int. J. Parasitol. 31: 753-762.
21. Doolan, D.L., Southwood, S., Chesnut, R., Appella, E., Gomez, E., Richards, A., Higashimoto, Y.I., Maewal, A., Sidney, J., Gramzinski, R.A., Mason, C., Koech, D., Hoffman, S.L., and Sette, A., 2000, HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. J. Immunol. 165: 1123-1137.
22. Edozien, J.C., Gilles, H.M., and Udezo, I.O.K., 1962, Adult and cord-blood gamma-globulin and immunity to malaria in Nigerians. Lancet 10: 951-955.
23. Ferreira, M.U., Kimura, E.A., De Souza, J.M., and Katzin, A.M., 1996, The isotype composition and avidity of naturally acquired anti-Plasmodium falciparum antibodies: differential patterns in clinically immune Africans and Amazonian patients. Am. J. Trop. Med. Hyg. 55: 315-323.
24. Fonjungo, P.N., Elhassan, I.M., Cavanagh, D.R., Theander, T.G., Hviid, L., Roper, C., Arnot, D.E., and McBride, J.S., 1999, A longitudinal study of human antibody responses to Plasmodium falciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission. Infect. Immun. 67(6): 2975-2985.
25. Hill, A.V., 2001, The genomics and genetics of human infectious disease susceptibility. Annu. Rev. Genomics Hum. Genet. 2: 373-400.
26. Jensen, J.B., and Trager, W., 1977, Plasmodium falciparum in culture: use of outdates erythrocytes and description of the candle jar method. Journal of Parasitology 63: 883-886.
27. Kurtis, J.D., Mtalib, R., Onyango, F.K., and Duffy, P.E., 2001, Human resistance to Plasmodium falciparum increases during puberty and is predicted by dehydroepiandrosterone sulfate levels. Infect. Immun. 69: 123-128.
28. Kwiatkowski, D., Bate, C.A., Scragg, I.G., Beattie, P., Udalova, I., and Knight, J.C. 1997, The malarial fever response - pathogenesis, polymorphism and prospects for intervention. Ann. Trop. Med. Parasitol. 91: 533-542.
29. Liang, H., and Sim, B.K., 1997, Conservation of structure and function of the erythrocyte-binding domain of Plasmodium falciparum EBA-175. Mol. Biochem., Parasitol. 84: 241-245.
30. Maitland, K., Williams, T.N., Bennet, S., Newbold, C.I., Peto, T.E.A., Viji, J., Timothy, R., Clegg, J.B., Weatheral, D.J. and Bowden, D.K., 1996, The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. Trans. R. Soc. Trop. Med. Hyg. 90: 614-620.
31. Marshall, V.M., Silva, A., Foley, M., Cranmer, S., Wang, L., McColl, D.J., Kemp, D.J., and Coppel, R.L., 1997, A second merozoite surface protein (MSP-4) of Plasmodium falciparum that contains an epidermal growth factor-like domain. Infect. Immun. 65: 4460-4467.
32. McGregor, I.A., 1987, Malarial immunity: current trends and prospects. Ann. Trop. Med. Parasitol. 81: 647-656.
33. McGregor, I.A., Carrington, S., and Cohen, S., 1963, Treatment of East African Plasmodium falciparum malaria with West African human gamma globulin. Trans. R. Soc. Trop. Med. Hyg. 57: 170-175.
34. McGregor, I.A., Gilles, H.M., Walters, J.H., Davies, A.H., and Pearson, F.A., 1956, Effects of heavy and repeated malarial infections on Gambain infants and children; effects of erythrocytic parasitization. Br. Med. J. ii: 686-692.
35. McGuire, W., Hill, A.V., Allsopp C.E., Greenwood, B.M., and Kwiatkowski, D., 1994, Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-510.
36. Melancon-Kaplan, J., Jr. B.J.M., Vaidya, A.B., Webster, H.K., and Weidanz, W.P., 1993, Malaria. In Immunology and Molecular Biology of Parasitic Infections (K. S. Warren ed.), 3rd edn. Blackwell Scientific Publications, New York.
37. Okenu, D.M., Riley, E.M., Bickle, Q.D., Agomo, P.U., Barbosa, A., Daugherty, J.R., Lanar, D.E., and Conway, D.J., 2000, Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum [In Process Citation]. Infect. Immun. 68: 5559-5566.
38. Pogo, A.O., and Chaudhuri, A., 2000, The Duffy protein: a malarial and chemokine receptor. Semin. Hematol. 37: 122-129.
39. Ramasamy, R., Ramasamy, M., and Yasawardena, S., 2001, Antibodies and Plasmodium falciparum merozoites. Trends Parasitol. 17: 194-197.
40. Sabchareon, A., Burnouf, T., Ouattara, D., Attanath, P., Bouharoun-Tayoun, H., Chantavanich, P., Foucault, C., Chongsuphajaisiddhi, T., and Druilhe, P., 1991, Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am. J. Trop. Med. Hyg, 45: 297-308.
41. Sadun, E.H., Hickman, R.L., Wellde, B.T., Moon, A.P., and Udeozo, I.O.K., 1966, Active and passive immunization of chimpanzees infected with West African and South East Asian strains of P. falciparum. Mil. Med. 31 (suppl.): 1250-1262.
42. Sarthou, J.L., Angel, G., Aribot, G., Rogier, C., Dieye, A., Toure Balde, A., Diatta, B., Seignot, P., and Roussilhon, C., 1997, Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria. Infect. Immun. 65: 3271-3276.
43. Shi, Y.P., Sayed, U., Qari, S.H., Roberts, J.M., Udhayakumar, V., Oloo, A.J., Hawley, W.A., Kaslow, D.C., Nahlen, B.L., and Lal, A.A., 1996, Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect. Immun. 64: 2716-2723.
44. Sim, B.K., Chitnis, C.E., Wasniowska, K., Hadley T.J., and Miller, L.H., 1994, Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. Science 264: 1941-1944.
45. Snow, R.W., and Marsh, K., 1998, New insights into the epidemiology of malaria relevant for disease control. Br. Med. Bull. 54: 293-309.
46. Taylor, R.R., Allen, S.J., Greenwood, B.M., and Riley, E.M., 1998, IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am. J. Trop. Med. Hyg. 58: 406-413.
47. Taylor, R.R., Smith, D.B., Robinson, V.J., McBride, J.S., and Riley, E.M., 1995, Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass. Infect. Immun. 63: 4382-4388.
48. Trape, J.F., Rogier, C., Konate, L., Diagne, N., Bouganali, H., Canque, B., Legros, F., Badji, A., Ndiaye, G., Ndiaye, P., et al., 1994, The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am. J. Trop. Med. Hyg. 51: 123-137.
49. Vulliamy, T., Mason, P., and Luzzatto, L., 1992, The molecular basis of glucose-6-phosphate dehydrogenase deficiency. Trends Genet. 8: 138-143.
50. Wattavidanage, J., Carter, R., Perera, K.L., Munasingha, A., Bandara, S., McGuinness, D., Wickramasinghe, A.R., Alles, H.K., Mendis, K.N., and Premawansa, S., 1999, TNFalpha*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans. Clin. Exp. Immunol. 115: 350-355.
51. Wilson, D.B., 1936, Rural hyper-endemic malaria in Tanganyika Territory. Trans. R.L. Soc. Trop. Med. Hyg. 29: 583-617.